Limited Access Trial Using Amifostine for Protection Against Cisplatin- and Three-Hour Paclitaxel–Induced Neurotoxicity: A Phase II Study of the Gynecologic Oncology Group (Q40549941)
Jump to navigation
Jump to search
scientific article published on November 15, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Limited Access Trial Using Amifostine for Protection Against Cisplatin- and Three-Hour Paclitaxel–Induced Neurotoxicity: A Phase II Study of the Gynecologic Oncology Group |
scientific article published on November 15, 2003 |
Statements
1 reference
Limited access trial using amifostine for protection against cisplatin- and three-hour paclitaxel-induced neurotoxicity: a phase II study of the Gynecologic Oncology Group (English)
1 reference
Limited Access Trial Using Amifostine for Protection Against Cisplatin- and Three-Hour Paclitaxel–Induced Neurotoxicity: A Phase II Study of the Gynecologic Oncology Group (English)
1 reference
1 reference
James Donnelly
1 reference
Lois Almadrones
1 reference
Gynecologic Oncology Group
1 reference
David H. Moore
William P. McGuire
David F. Cella
Thomas J. Herzog
Steven E. Waggoner
1 November 2003
1 reference
15 November 2003
1 reference
4207-4213
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference